ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Lidonnici et al. [46] speculated that miR-150 reduction might contribute to the c-MYB upregulation that is likely induced by BCR-ABL, and may be involved in BCR-ABL driven leukemogenesis in CML.